Jiangsu Sihuan Bioengineering (000518.SZ) has announced a predicted loss, with an estimated net loss between 68 million and 100 million yuan for the year 2024.

Jiangsu Sihuan Bioengineering (000518.SZ) has released its performance forecast for the year 2024, estimating a net loss attributable to shareholders of the listed company of between 68 million to 100 million yuan. The main reasons for the performance loss are: increased expenses due to a dispute over securities false statements responsibility; a decrease in revenue from the main business of Beijing Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd. caused by competition in the pharmaceutical market; a decrease in the value of inventory assets (seedlings) of Jiangsu Chenwei Ecological Park Technology Co., Ltd. due to market conditions leading to price drops; and a certain amount of damage to the seedling inventory due to extreme weather such as prolonged high temperatures and typhoons in the summer of 2024 and regular maintenance.